Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Researchers identify enzyme that protects against inflammation, joint destruction

A team of researchers at the University of Gothenburg, Sweden, has identified an enzyme that protects against inflammation and joint destruction. Made when the researchers blocked production of the enzyme GGTase-I in transgenic mice, this unexpected discovery could lead to the identification of new mechanisms that control the development of inflammatory disorders, as well as new medicines.

8 Feb 2011

Two new sources of soybean may replace fish meal in weanling pig diets

Two new sources of soybean meal are capturing attention throughout the country. University of Illinois research indicates that fermented soybean meal and enzyme-treated soybean meal may replace fish meal in weanling pig diets.

7 Feb 2011

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

7 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

7 Feb 2011

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into an exclusive worldwide (except Japan) agreement by which Salix has licensed rights to RELISTOR® (methylnaltrexone bromide).

7 Feb 2011

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.

7 Feb 2011

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

Accidental damage to thin or buried nerves during surgery can have severe consequences, from chronic pain to permanent paralysis. Scientists at the University of California, San Diego School of Medicine may have found a remedy: injectable fluorescent peptides that cause hard-to-see peripheral nerves to glow, alerting surgeons to their location even before the nerves are encountered.

6 Feb 2011

Maxygen distributes Codexis's shares to its stockholders for U.S. Federal income tax purposes

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its distributions of Codexis, Inc. common stock and cash in December 2010 will be classified as a return of capital to its stockholders for U.S. Federal income tax purposes.

5 Feb 2011

New understanding of how host and foreign structures are distinguished by front-line defence mechanism

This week, the highly-respected US Academy of Sciences journal (PNAS) published an article describing how the first line of defence of the human immune system distinguishes between microbes and the body's own structures.

5 Feb 2011

Dermatologist's tips to reverse damage and maintain healthy, lustrous hair

While the latest hairstyles and hair colors may look great, dermatologists warn that many women are subjecting their hair to harsh chemicals and heated styling devices that, in turn, can damage the hair. Over time, lustrous hair can look lackluster, become brittle and require a complete hair care overhaul to improve hair health and appearance.

5 Feb 2011

Novel study finds unexpected link between reproductive proteins in humans, invertebrates

A novel study in the scientific journal Molecular Biology and Evolution draws a completely unexpected link between reproductive proteins in humans and proteins involved in fertilization in invertebrates, as well as mating between haploid cells in yeast. Because human and yeast are separated by 1 billion years of evolution, these findings may have important implications for our understanding of the molecular mechanisms underlying sex, and how they originated.

5 Feb 2011

Research provides new clues to understand link between deficits of AGPO-3, depression

The link between deficits of omega-3 poly-unsaturated fatty acids and the onset of depressive disorders is not new in the medical field. However, what has not been known until now is the brain mechanism by which diet can condition mental health to a certain extent.

5 Feb 2011

Lack of DOT1L enzyme could lead to some types of heart disease: Study

Everyone knows chocolate is critical to a happy Valentine's Day. Now scientists are one step closer to knowing what makes a heart happy the rest of the year.

5 Feb 2011

Scientists discover how stressed cells boost thrombin production

In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body's stress response is to stock-pile blood-clotting factors. Scientists in the Molecular Medicine Partnership Unit, a collaboration between the European Molecular Biology Laboratory in Heidelberg, Germany, and the University of Heidelberg Medical Centre, have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin.

4 Feb 2011

Scientists discover how stressed cells boost production of key blood-clotting factor, thrombin

Scientists in a collaboration between EMBL Heidelberg and the University of Heidelberg Medical Centre have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin. Their work, published today in Molecular Cell, shows how cancer cells may be taking advantage of this process, and opens new possibilities for fighting back against cancer and septicaemia.

4 Feb 2011

How body's first line of defence distinguishes between microbes and own structures

4 Feb 2011

Research unmasks long sought stem cell origin of carcinoma

A constellation of different stem cell populations within our skin help it to cope with normal wear and tear. By constantly proliferating, the stem cells allow skin to replenish itself, allowing each cell to be replaced by a new one about once a month. But the normal cycle of division and death within one or more of these stem cell types can sometimes be derailed by genetic mishaps. Such events are believed to spawn carcinomas and other deadly skin cancers, which are the mostly frequently diagnosed cancers in the United States.

4 Feb 2011

More needs to be done globally to fight cancer

WHILE cancer statistics for the last 10 years make encouraging reading, more needs to be done globally to fight the killer disease.

4 Feb 2011

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

4 Feb 2011

New way to stabilize proteins

A team of scientists at The Scripps Research Institute has discovered a new way to stabilize proteins — the workhorse biological macromolecules found in all organisms. Proteins serve as the functional basis of many types of biologic drugs used to treat everything from arthritis, anemia, and diabetes to cancer.

4 Feb 2011

Protein News and Research

Further Reading

Researchers identify enzyme that protects against inflammation, joint destruction

Two new sources of soybean may replace fish meal in weanling pig diets

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

Maxygen distributes Codexis's shares to its stockholders for U.S. Federal income tax purposes

New understanding of how host and foreign structures are distinguished by front-line defence mechanism

Dermatologist's tips to reverse damage and maintain healthy, lustrous hair

Novel study finds unexpected link between reproductive proteins in humans, invertebrates

Research provides new clues to understand link between deficits of AGPO-3, depression

Lack of DOT1L enzyme could lead to some types of heart disease: Study

Scientists discover how stressed cells boost thrombin production

Scientists discover how stressed cells boost production of key blood-clotting factor, thrombin

How body's first line of defence distinguishes between microbes and own structures

Research unmasks long sought stem cell origin of carcinoma

More needs to be done globally to fight cancer

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

New way to stabilize proteins

A guide to advancing biotherapeutic research eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo